Table 1. Comparison of 15-year completeness indices, by cancer site and sex.
| Maddams et ala | EUROPREVALb | |
|---|---|---|
| Males | ||
| Colon, rectum and anus | 0.81 | 0.87c |
| Lung, bronchus and trachea | 0.58 | 0.73d |
| Prostate | 0.95 | 0.97 |
| All malignant neoplasmse | 0.78 | 0.82 |
| Females | ||
| Breast | 0.74 | 0.80 |
| Colon, rectum and anus | 0.74 | 0.80 |
| Lung, bronchus and trachea | 0.77 | 0.79 |
| All malignant neoplasmse | 0.70 | 0.72 |
ICD=International Classification of Diseases.
The 15-year completeness index is defined as 15-year prevalence divided by complete prevalence.
a
15-year prevalence divided by estimated complete prevalence in the United Kingdom. Index date: 31 December 2004.
b
Average 15-year completeness index for prevalence as estimated using data from South Thames, West Midlands, Yorkshire and Scotland cancer registries. Index date: 31 December 1992. Published by Forman et al (2003), Ann Oncol 14: 648–654.
c
Average of indices for cancers of the colon and rectum.
d
Cancer of the lung only.
e
Excluding non-melanoma skin cancer (ICD-10 C44).